Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.
Breast Cancer Research : Bcr
Tinholt, Mari M; Vollan, Hans Kristian Moen HK; Sahlberg, Kristine Kleivi KK; Jernström, Sandra S; Kaveh, Fatemeh F; Lingjærde, Ole Christian OC; Kåresen, Rolf R; Sauer, Torill T; Kristensen, Vessela V; Børresen-Dale, Anne-Lise AL; Sandset, Per Morten PM; Iversen, Nina N
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study.
Bmc Cancer
Tinholt, Mari M; Viken, Marte Kathrine MK; Dahm, Anders Erik AE; Vollan, Hans Kristian Moen HK; Sahlberg, Kristine Kleivi KK; Garred, Oystein O; Børresen-Dale, Anne-Lise AL; Jacobsen, Anne Flem AF; Kristensen, Vessela V; Bukholm, Ida I; Kåresen, Rolf R; Schlichting, Ellen E; Skretting, Grethe G; Lie, Benedicte Alexandra BA; Sandset, Per Morten PM; Iversen, Nina N
Association of warfarin dose with genes involved in its action and metabolism.
Human Genetics
Wadelius, Mia M; Chen, Leslie Y LY; Eriksson, Niclas N; Bumpstead, Suzannah S; Ghori, Jilur J; Wadelius, Claes C; Bentley, David D; McGinnis, Ralph R; Deloukas, Panos P